New Mexico Educational Retirement Board Has $731,000 Stock Holdings in ICU Medical, Incorporated (NASDAQ:ICUI)

Share on StockTwits

New Mexico Educational Retirement Board cut its position in ICU Medical, Incorporated (NASDAQ:ICUI) by 14.7% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,900 shares of the medical instruments supplier’s stock after selling 500 shares during the period. New Mexico Educational Retirement Board’s holdings in ICU Medical were worth $731,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Rhumbline Advisers raised its holdings in shares of ICU Medical by 1.3% during the first quarter. Rhumbline Advisers now owns 45,901 shares of the medical instruments supplier’s stock worth $10,985,000 after acquiring an additional 575 shares during the period. AGF Investments LLC raised its holdings in shares of ICU Medical by 55.7% during the second quarter. AGF Investments LLC now owns 1,476 shares of the medical instruments supplier’s stock worth $372,000 after acquiring an additional 528 shares during the period. Texas Permanent School Fund raised its holdings in shares of ICU Medical by 3.8% during the first quarter. Texas Permanent School Fund now owns 11,274 shares of the medical instruments supplier’s stock worth $2,698,000 after acquiring an additional 414 shares during the period. ARP Americas LP acquired a new stake in shares of ICU Medical during the first quarter worth $212,000. Finally, WCM Investment Management LLC acquired a new stake in shares of ICU Medical during the first quarter worth $1,512,000. Institutional investors own 92.47% of the company’s stock.

In other news, Director Robert S. Swinney sold 2,078 shares of ICU Medical stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $165.18, for a total value of $343,244.04. Following the completion of the transaction, the director now owns 17,345 shares of the company’s stock, valued at approximately $2,865,047.10. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Scott E. Lamb sold 25,000 shares of ICU Medical stock in a transaction dated Wednesday, June 26th. The shares were sold at an average price of $250.00, for a total transaction of $6,250,000.00. Following the completion of the transaction, the chief financial officer now directly owns 34,984 shares of the company’s stock, valued at approximately $8,746,000. The disclosure for this sale can be found here. In the last three months, insiders sold 34,661 shares of company stock valued at $8,354,148. Insiders own 11.40% of the company’s stock.

ICUI has been the topic of a number of research analyst reports. ValuEngine lowered shares of ICU Medical from a “hold” rating to a “sell” rating in a report on Thursday, August 8th. BidaskClub lowered shares of ICU Medical from a “buy” rating to a “hold” rating in a report on Wednesday, August 14th. Raymond James lowered shares of ICU Medical from a “strong-buy” rating to an “outperform” rating in a report on Thursday, August 8th. TheStreet lowered shares of ICU Medical from a “b-” rating to a “c+” rating in a report on Monday, August 12th. Finally, Zacks Investment Research lowered shares of ICU Medical from a “hold” rating to a “sell” rating in a report on Wednesday, August 14th. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and one has given a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $290.50.

ICUI stock traded down $0.76 during midday trading on Wednesday, hitting $157.94. The company’s stock had a trading volume of 6,482 shares, compared to its average volume of 325,111. ICU Medical, Incorporated has a twelve month low of $158.52 and a twelve month high of $312.45. The company’s fifty day moving average price is $216.98 and its 200 day moving average price is $231.29. The stock has a market capitalization of $3.34 billion, a P/E ratio of 20.49 and a beta of 0.81.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings results on Wednesday, August 7th. The medical instruments supplier reported $1.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.86 by $0.13. ICU Medical had a net margin of 3.56% and a return on equity of 12.41%. The firm had revenue of $312.30 million for the quarter, compared to analyst estimates of $315.47 million. During the same period in the previous year, the business earned $2.69 EPS. The company’s revenue was down 13.4% compared to the same quarter last year. As a group, equities research analysts forecast that ICU Medical, Incorporated will post 7.21 earnings per share for the current fiscal year.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Featured Article: What is the yield curve?

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Verisk Analytics  Price Target Increased to $164.00 by Analysts at Morgan Stanley
Verisk Analytics Price Target Increased to $164.00 by Analysts at Morgan Stanley
Solar Senior Capital  Downgraded by Zacks Investment Research
Solar Senior Capital Downgraded by Zacks Investment Research
TTEC  Cut to “Buy” at BidaskClub
TTEC Cut to “Buy” at BidaskClub
Tricida  Lifted to “Hold” at Zacks Investment Research
Tricida Lifted to “Hold” at Zacks Investment Research
Inovalon  Lifted to Buy at Zacks Investment Research
Inovalon Lifted to Buy at Zacks Investment Research
i3 Verticals  Downgraded by ValuEngine to Hold
i3 Verticals Downgraded by ValuEngine to Hold


© 2006-2019 Ticker Report